Tuesday, 07 Apr 2020

You are here

Lupus Flares After Renal Transplant

Whether lupus activity is ameliorated by end-stage renal disease (ESRD) or transplantation has been debated.  A recent report from Mexico City assessed the frequency and risks for extrarenal flare in SLE patients after renal transplant. A retrospective, case–control study studied 38 SLE cases (who experienced 50 extrarenal flares) and 50 controls seen between 1993 to 2014.

Flares were more common in men and the most common flares were hematologic (42%), mucocutaneous (38%) and articular (30%). Independent risk factors for flares included age at the start of renal replacement therapy [OR 0.92 (95% CI 0.88, 0.96)], history of haematologic activity [OR 3.79 (95% CI 1.05, 13.7)], anti-cardiolipin IgM [OR 4.39 (95% CI 1.32, 14.6)] and low C4 levels [OR 9.7 (95% CI 2.49, 39.12)].

Hence there may be a profile for lupus patients at risk for extrarenal flare after RRT.  Closer monitoring may be warranted in younger patients, with history of hematologic disease, anti-cardiolipin antibodies or lower C4 levels. 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

In Lupus, Keep BP Below 130/80

Blood pressure should be maintained at a level below 130/80 mm Hg in all patients with lupus to lessen their likelihood of atherosclerotic vascular events, Canadian researchers asserted.

In Vasculitis, Beware of Infection

Risks of infection were strikingly high among patients with antineutrophil cytoplasmic antibody-associated (ANCA) vasculitis, which may relate to both the disease and its treatment, Scottish researchers found.

Malignancies with Giant Cell Arteritis

The Journal of Rheumatology reports the findings of a Swedish population-based cohort study of biopsy-proven giant cell arteritis (GCA) patients showing that the overall risk for cancer was not increased; yet there appears to be an increased risk for leukemia and a decreased risk for breast and upper gastrointestinal tract cancers.   

Hospitalized GPA - Higher morbidity, Mortality and Cost

Rheumatology reports on a study of patients with granulomatosis with polyangiitis (GPA) showing worse outcomes and higher costs when hospitalized with GPA.

GPA patients were identified from the Nationwide Inpatient Sample (NIS) and were compared to those without GPA with regard to demographics, procedures, length of stay, mortality, morbidity and total hospitalization charges (between 2005–2014).

Don't Blame the Weather in Sjogren's

Seasonal variations in symptoms -- commonly reported by patients with rheumatic diseases -- were not observed in a large cohort of patients with primary Sjogren's syndrome, French investigators found.